{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T21:47:40Z","timestamp":1782164860548,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12887-018-1137-4","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T13:39:13Z","timestamp":1525441153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Opioid substitution treatment and heroin dependent adolescents: reductions in heroin use and treatment retention over twelve months"],"prefix":"10.1186","volume":"18","author":[{"given":"Bobby P.","family":"Smyth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalifa","family":"Elmusharaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"key":"1137_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jadohealth.2016.12.023","volume":"60","author":"KA Feder","year":"2017","unstructured":"Feder KA, Krawczyk N, Saloner B. Medication-assisted treatment for adolescents in specialty treatment for opioid use disorder. J Adoles Health. 2017;60:747\u201350. \n                    https:\/\/doi.org\/10.1016\/j.jadohealth.2016.12.023\n                    \n                  .","journal-title":"J Adoles Health"},{"key":"1137_CR2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-1211","volume":"138","author":"S Levy","year":"2016","unstructured":"Levy S, Ryan SA, Gonzalez PK, Patrick SW, Quigley J, Siqueira L, et al. Medication-assisted treatment of adolescents with opioid use disorders. Pediatrics. 2016;138:e20161893. \n                    https:\/\/doi.org\/10.1542\/peds.2016-1893\n                    \n                  .","journal-title":"Pediatrics"},{"key":"1137_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000076116","volume":"10","author":"BP Smyth","year":"2004","unstructured":"Smyth BP, O\u2019Brien M. Children attending addiction treatment services in Dublin, 1990\u20131999. Eur Addiction Res. 2004;10:68\u201374. \n                    https:\/\/doi.org\/10.1159\/000076116\n                    \n                  .","journal-title":"Eur Addiction Res"},{"issue":"4","key":"1137_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0740-5472(01)00174-X","volume":"20","author":"M Gervin","year":"2001","unstructured":"Gervin M, Hughes R, Bamford L, Smyth BP, Keenan E. Heroin smoking by \u201cchasing the dragon\u201d in young opiate users in Ireland: stability and associations with use to \u201ccome down\u201d off \u201cecstasy\u201d. J Subst Abus Treat. 2001;20(4):297\u2013300.","journal-title":"J Subst Abus Treat"},{"key":"1137_CR5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1046\/j.1360-0443.1998.9345157.x","volume":"93","author":"L Marsch","year":"1998","unstructured":"Marsch L. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction. 1998;93:515\u201332.","journal-title":"Addiction"},{"key":"1137_CR6","doi-asserted-by":"publisher","unstructured":"Minozzi S, Amato L, Bellisario C, Davoli M. Maintenance treatments for opiate -dependent adolescents . Cochrane Database of Systematic Reviews 2014, Issue 6. Art. No.: CD007210. \n                    https:\/\/doi.org\/10.1002\/14651858.CD007210.pub3\n                    \n                  .","DOI":"10.1002\/14651858.CD007210.pub3"},{"key":"1137_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1749-6632.1978.tb16772.x","volume":"311","author":"RB Millman","year":"1978","unstructured":"Millman RB, Khuri ET, Nyswander ME. Therapeutic detoxification of adolescent heroin addicts. Ann N Y Acad Sci. 1978;311:153\u201364.","journal-title":"Ann N Y Acad Sci"},{"key":"1137_CR8","first-page":"571","volume-title":"Youth drug abuse: problems, issues and treatment","author":"SB Sells","year":"1979","unstructured":"Sells SB, Simpson DD. Evaluation of treatment outcome for youths in the drug abuse reporting program (DARP): a follow-up study. In: Beschner GM, Friedman AA, editors. Youth drug abuse: problems, issues and treatment. Lanham, MD: Lexington Books; 1979. p. 571\u2013622."},{"key":"1137_CR9","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2008.574","volume":"300","author":"GE Woody","year":"2008","unstructured":"Woody GE, Poole SA, Subramaniam G, Dugosh K, Bogenschutz M, Abbott P, et al. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA. 2008;300:2003\u201311. \n                    https:\/\/doi.org\/10.1001\/jama.2008.574\n                    \n                  .","journal-title":"JAMA"},{"key":"1137_CR10","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.jaac.2011.07.010","volume":"50","author":"GA Subramaniam","year":"2011","unstructured":"Subramaniam GA, Warden D, Minhajuddin A, Fishman MJ, Stitzer ML, Adinoff B, et al. Predictors of abstinence: National Institute of drug abuse multisite buprenorphine\/naloxone treatment trial in opioid-dependent youth. J Am Acad Child & Adoles Psychiatry. 2011;50:1120\u20138. \n                    https:\/\/doi.org\/10.1016\/j.jaac.2011.07.010\n                    \n                  .","journal-title":"J Am Acad Child & Adoles Psychiatry"},{"key":"1137_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1017\/S0021963099004965","volume":"41","author":"E Gilvarry","year":"2000","unstructured":"Gilvarry E. Substance abuse in young people. J Child Psychol & Psychiatry. 2000;41:55\u201380.","journal-title":"J Child Psychol & Psychiatry"},{"key":"1137_CR12","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.drugpo.2015.05.021","volume":"26","author":"BP Smyth","year":"2015","unstructured":"Smyth BP, James P, Cullen W, Darker C. So prohibition can work? Changes in use of novel psychoactive substances among adolescents attending a drug and alcohol treatment service following a legislative ban Int J Drugs Policy. 2015;26:887\u20139. \n                    https:\/\/doi.org\/10.1016\/j.drugpo.2015.05.021\n                    \n                  .","journal-title":"Changes in use of novel psychoactive substances among adolescents attending a drug and alcohol treatment service following a legislative ban Int J Drugs Policy"},{"key":"1137_CR13","first-page":"137","volume":"108","author":"BP Smyth","year":"2015","unstructured":"Smyth BP, Kelly A, Cullen W, Darker C. Outcome for adolescents abusing alcohol and cannabis following outpatient treatment: how many \u2018reliably improve\u2019? Irish Med J. 2015;108:137\u20139.","journal-title":"Irish Med J"},{"key":"1137_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1046\/j.1360-0443.2003.00296.x","volume":"98","author":"M Gossop","year":"2003","unstructured":"Gossop M, Marsden J, Stewart D, Kidd T. The National Treatment Outcome Research Study (NTORS): 4\u20135 year follow-up results. Addiction. 2003;98:291\u2013303.","journal-title":"Addiction"},{"key":"1137_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1300\/J069v25n03_03","volume":"25","author":"S Kellogg","year":"2006","unstructured":"Kellogg S, Melia D, Khuri E, Lin A, Ho A, Kreek MJ. Adolescent and young adult heroin patients: drug use and success in methadone maintenance treatment. J Addict Disease. 2006;25:15\u201325. \n                    https:\/\/doi.org\/10.1300\/J069v25n03_03\n                    \n                  .","journal-title":"J Addict Disease"},{"key":"1137_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/09595230500537670","volume":"25","author":"J Bell","year":"2006","unstructured":"Bell J, Mutch C. Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review. Drug Alcohol Rev. 2006;25:167\u201371. \n                    https:\/\/doi.org\/10.1080\/09595230500537670\n                    \n                  .","journal-title":"Drug Alcohol Rev"},{"key":"1137_CR17","doi-asserted-by":"publisher","unstructured":"Matson SC, Hobson G, Abdel-Rasoul M, Bonny AE. A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine\/naloxone clinic. J Addict Med. 2014:8176\u201382. \n                    https:\/\/doi.org\/10.1097\/ADM.0000000000000035\n                    \n                  .","DOI":"10.1097\/ADM.0000000000000035"},{"key":"1137_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2016.04.002","volume":"67","author":"C Mutlu","year":"2016","unstructured":"Mutlu C, Demirci AC, Yalcin O, Kilicoglu AG, Topal M, Karacetin G. One-year follow-up of heroin-dependent adolescents treated with Buprenorfine\/naloxone for the first time in a substance treatment unit. J Subst Abus Treat. 2016;67:1\u20138. \n                    https:\/\/doi.org\/10.1016\/j.jsat.2016.04.002\n                    \n                  .","journal-title":"J Subst Abus Treat"},{"key":"1137_CR19","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.addbeh.2012.04.011","volume":"37","author":"D Warden","year":"2012","unstructured":"Warden D, Subramaniam GA, Carmody T, Woody GE, Minhajuddin A, Poole SA, et al. Predictors of attrition with buprenorphine\/naloxone treatment in opioid dependent youth. Addict Behaviors. 2012;37:1046\u201353. \n                    https:\/\/doi.org\/10.1016\/j.addbeh.2012.04.011\n                    \n                  .","journal-title":"Addict Behaviors"},{"key":"1137_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jsat.2011.07.007","volume":"42","author":"BP Smyth","year":"2012","unstructured":"Smyth BP, Fagan J, Kernan K. Outcome of heroin-dependent adolescents presenting for opiate substitution treatment. J Subst Abus Treat. 2012;42:35\u201344. \n                    https:\/\/doi.org\/10.1016\/j.jsat.2011.07.007\n                    \n                  .","journal-title":"J Subst Abus Treat"},{"key":"1137_CR21","doi-asserted-by":"publisher","unstructured":"Smyth BP, Ducray K, Cullen W. Changes in psychological well-being among heroin-dependent adolescents during psychologically supported opiate substitution treatment. Early Interv Psychiatry. 2016; \n                    https:\/\/doi.org\/10.1111\/eip.12318\n                    \n                  .","DOI":"10.1111\/eip.12318"},{"key":"1137_CR22","unstructured":"Department of Health. Guidance for the pharmacological management of substance misuse among young people. London: Department of Health, 2009. \n                    http:\/\/webarchive.nationalarchives.gov.uk\/20130124051653\/http:\/\/www.dh.gov.uk\/prod_consum_dh\/groups\/dh_digitalassets\/documents\/digitalasset\/dh_106429.pdf\n                    \n                   (accessed 5 Jan 2018)."},{"issue":"1","key":"1137_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1360-0443.2011.03577.x","volume":"107","author":"L Amass","year":"2012","unstructured":"Amass L, Pukeleviciene V, Subata E, Almeida AR, Pieri MC, D'egidio P, Stankova Z, Costa A, Smyth BP, Sakoman S, Wei Y. A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine\/naloxone induction in heroin-dependent individuals. Addiction. 2012 Jan 1;107(1):142\u201351. \n                    https:\/\/doi.org\/10.1111\/j.1360-0443.2011.03577.x\n                    \n                  .","journal-title":"Addiction"},{"key":"1137_CR24","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1046\/j.1360-0443.1998.9312185711.x","volume":"93","author":"J Marsden","year":"1998","unstructured":"Marsden J, Gossop M, Stewart D, et al. The Maudsley addiction profile (MAP): a brief instrument for assessing treatment outcome. Addiction. 1998;93:1857\u201367.","journal-title":"Addiction"},{"issue":"7","key":"1137_CR25","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/jech.53.7.434","volume":"53","author":"BP Smyth","year":"1999","unstructured":"Smyth BP, Keenan E, O'Connor JJ. Evaluation of the impact of Dublin's expanded harm reduction programme on prevalence of hepatitis C among short-term injecting drug users. J Epid Comm Health. 1999;53(7):434.","journal-title":"J Epid Comm Health"},{"issue":"1","key":"1137_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1360-0443.2007.02029.x","volume":"103","author":"M Teesson","year":"2008","unstructured":"Teesson M, Mills K, Ross J, Darke S, Williamson A, Havard A. The impact of treatment on 3 years\u2019 outcome for heroin dependence: findings from the Australian treatment outcome study (ATOS). Addiction. 2008;103(1):80\u20138. \n                    https:\/\/doi.org\/10.1111\/j.1360-0443.2007.02029.x\n                    \n                  .","journal-title":"Addiction"},{"key":"1137_CR27","first-page":"393","volume":"100","author":"F Kamal","year":"2007","unstructured":"Kamal F, Flavin S, Campbell F, Behan C, Fagan J, Smyth R. Factors affecting the outcome of methadone maintenance treatment in opiate dependence. Irish Med J. 2007;100:393\u20137.","journal-title":"Irish Med J"},{"key":"1137_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.drugalcdep.2005.08.010","volume":"81","author":"A Williamson","year":"2006","unstructured":"Williamson A, Darke S, Ross J, Teesson M. The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence. Drug Alcohol Depend. 2006;81:293\u2013300. \n                    https:\/\/doi.org\/10.1016\/j.drugalcdep.2005.08.010\n                    \n                  .","journal-title":"Drug Alcohol Depend"},{"key":"1137_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/10550490050173217","volume":"9","author":"PA DeMaria","year":"2000","unstructured":"DeMaria PA, Sterling R, Weinstein SP. The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment. Am J Addict. 2000;9:145\u201353.","journal-title":"Am J Addict"},{"key":"1137_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jsat.2015.01.009","volume":"54","author":"AR Levine","year":"2015","unstructured":"Levine AR, Lundahl LH, Ledgerwood DM, Lisiesko M, Rhodes GL, Greenwald MK. J gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment. Subst Abuse Treat. 2015;54:37\u201343. \n                    https:\/\/doi.org\/10.1016\/j.jsat.2015.01.009\n                    \n                  .","journal-title":"Subst Abuse Treat"},{"issue":"4","key":"1137_CR31","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11845-011-0803-4","volume":"181","author":"C Darker","year":"2012","unstructured":"Darker C, Sweeney B, El Hassan H, Kelly AS, O\u2019Connor S, Smyth B, Barry J. Non-attendance at counselling therapy in cocaine-using methadone-maintained patients: lessons learnt from an abandoned randomised controlled trial. Irish J Med Sci. 2012;181(4):483\u20139. \n                    https:\/\/doi.org\/10.1007\/s11845-011-0803-4\n                    \n                  .","journal-title":"Irish J Med Sci"},{"issue":"S1","key":"1137_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3109\/09687637.2010.514801","volume":"17","author":"J Orford","year":"2010","unstructured":"Orford J, Copello A, Velleman R, Templeton L. Family members affected by a close relative's addiction: the stress-strain-coping-support model. Drugs: education, prevention and policy. 2010;17(S1):36\u201343. \n                    https:\/\/doi.org\/10.3109\/09687637.2010.514801\n                    \n                  .","journal-title":"Drugs: education, prevention and policy"},{"key":"1137_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/00952999309001617","volume":"19","author":"L Goehl","year":"1993","unstructured":"Goehl L, Nunes E, Quitkin F, Hilton I. Social networks and methadone treatment outcome: the costs and benefits of social ties. Am J Drug Alcohol Abuse. 1993;19:251\u201362.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"1137_CR34","first-page":"176","volume":"103","author":"BP Smyth","year":"2010","unstructured":"Smyth BP, Barry J, Keenan E, Ducray K. Lapse and relapse following inpatient treatment of opiate dependence. Irish Med J. 2010;103:176\u20139.","journal-title":"Irish Med J"},{"issue":"4","key":"1137_CR35","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1545-5300.2010.01333.x","volume":"49","author":"S Ruff","year":"2010","unstructured":"Ruff S, McCOMB JL, Coker CJ, Sprenkle DH. Behavioral couples therapy for the treatment of substance abuse: a substantive and methodological review of O'Farrell, Fals-Stewart, and Colleagues\u2019 program of research. Fam Process. 2010;49(4):439\u201356. \n                    https:\/\/doi.org\/10.1111\/j.1545-5300.2010.01333.x\n                    \n                  .","journal-title":"Fam Process"},{"key":"1137_CR36","first-page":"87","volume":"7","author":"IB Crome","year":"2000","unstructured":"Crome IB, Christian J, Green C. The development of a unique designated community drug service for adolescents: policy prevention education implication. Drugs: Educ, Prevent Policy. 2000;7:87\u2013108.","journal-title":"Drugs: Educ, Prevent Policy"},{"key":"1137_CR37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1201\/9781322610207","volume-title":"Adolescents and substance use: the handbook for professionals working with young people","author":"P James","year":"2013","unstructured":"James P, Kearns C, Campbell A, Smyth BP. Adolescents and substance use: the handbook for professionals working with young people. Oxford: Radcliffe Publishing; 2013. p. 100\u20139."},{"issue":"3","key":"1137_CR38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/0959523031000154445","volume":"22","author":"S Dawe","year":"2003","unstructured":"Dawe S, Harnett PH, Rendalls V, Staiger P. Improving family functioning and child outcome in methadone maintained families: the parents under pressure programme. Drug Alc Review. 2003;22(3):299\u2013307. \n                    https:\/\/doi.org\/10.1080\/0959523031000154445\n                    \n                  .","journal-title":"Drug Alc Review"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-018-1137-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-018-1137-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-018-1137-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T23:04:57Z","timestamp":1556924697000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-018-1137-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1137"],"URL":"https:\/\/doi.org\/10.1186\/s12887-018-1137-4","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,4]]},"assertion":[{"value":"19 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study received ethical approval from the research ethics committee of the National Drug Treatment Centre, and this committee agreed that consent from individual patients was not required for this study. Only routinely gathered patient information was obtained. Patient specific information was not made available to anyone external to the clinical service where they were treated. This approach to consent is consistent with national data protection guidelines (see ).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"BPS has received lecture fees from Pfizer, Shire and Eli Lilly. BPS was a co-PI in a RCT examining buprenorphine induction which recruited patients from the NDTC. That RCT was funded by Schering-Plough (now Merck), a distributor of buprenorphine worldwide. BPS was the lead clinician at the treatment service (the YPP) where this study was conducted. BPS has no other competing interest. Neither KE nor WC has any competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"151"}}